Abstract B123: Preclinical evaluation of FS102: A HER2-specific Fcab with a novel mechanism of action.
Year: 2013
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: F-star (United Kingdom)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2084136102
